Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
The aim of this article is to represent the characterization of the clinical case of chemotherapy-related atrial fibrillation (AF) development in the young woman, elaborated as a result of multiple neoadjuvant and adjuvant modes of the intake of chemotherapy (both anthracycline based and non-anthrac...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2592 |
| _version_ | 1797232063463555072 |
|---|---|
| author | A. A. Avagimyan L. H. Mkrtchyan A. A. Gevorkyan N. B. Kononchuk L. V. Kakturskiy Z. T. Djndoyan |
| author_facet | A. A. Avagimyan L. H. Mkrtchyan A. A. Gevorkyan N. B. Kononchuk L. V. Kakturskiy Z. T. Djndoyan |
| author_sort | A. A. Avagimyan |
| collection | DOAJ |
| description | The aim of this article is to represent the characterization of the clinical case of chemotherapy-related atrial fibrillation (AF) development in the young woman, elaborated as a result of multiple neoadjuvant and adjuvant modes of the intake of chemotherapy (both anthracycline based and non-anthracycline ones). In this case, the noted disturbances of heart rhythm should be recognized as a manifestation of cardiotoxicity. The latter implies the degree of detrimental effect of chemotherapeutical medication on the morphophynctional parameters of the cardiovascular system. Anthracycline drugs, being highly effective chemotherapytical agents, provide well-known toxic effects on the heart and vessels. Anthracycline mediated cardiotoxicity is a well- known veracity that dates back to the 60s of the last century, but up to now this medication sustains irreplaceable components of big volume of chemotherapy modes. Moreover, it should be noted that relatively newer drugs also posses certain cardiotoxicogenic potential. |
| first_indexed | 2024-03-08T14:00:40Z |
| format | Article |
| id | doaj.art-ff68c49d7e9e4ad1a27783d839f84210 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:54:19Z |
| publishDate | 2021-11-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-ff68c49d7e9e4ad1a27783d839f842102024-04-01T07:43:41ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532021-11-0117578579110.20996/1819-6446-2021-10-171957Relationship between Chemotherapy and Atrial Fibrillation: Clinical CaseA. A. Avagimyan0L. H. Mkrtchyan1A. A. Gevorkyan2N. B. Kononchuk3L. V. Kakturskiy4Z. T. Djndoyan5Yerevan State Medical University after M. HeratsiYerevan State Medical University after M. HeratsiYerevan State Medical University after M. HeratsiMinsk City Clinical Hospital of Emergency CareResearch Institute of Human MorphologyYerevan State Medical University after M. HeratsiThe aim of this article is to represent the characterization of the clinical case of chemotherapy-related atrial fibrillation (AF) development in the young woman, elaborated as a result of multiple neoadjuvant and adjuvant modes of the intake of chemotherapy (both anthracycline based and non-anthracycline ones). In this case, the noted disturbances of heart rhythm should be recognized as a manifestation of cardiotoxicity. The latter implies the degree of detrimental effect of chemotherapeutical medication on the morphophynctional parameters of the cardiovascular system. Anthracycline drugs, being highly effective chemotherapytical agents, provide well-known toxic effects on the heart and vessels. Anthracycline mediated cardiotoxicity is a well- known veracity that dates back to the 60s of the last century, but up to now this medication sustains irreplaceable components of big volume of chemotherapy modes. Moreover, it should be noted that relatively newer drugs also posses certain cardiotoxicogenic potential.https://www.rpcardio.online/jour/article/view/2592cardiotoxicitycardio-oncologyatrial fibrillationchemotherapyanthracyclines |
| spellingShingle | A. A. Avagimyan L. H. Mkrtchyan A. A. Gevorkyan N. B. Kononchuk L. V. Kakturskiy Z. T. Djndoyan Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case Рациональная фармакотерапия в кардиологии cardiotoxicity cardio-oncology atrial fibrillation chemotherapy anthracyclines |
| title | Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
| title_full | Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
| title_fullStr | Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
| title_full_unstemmed | Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
| title_short | Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
| title_sort | relationship between chemotherapy and atrial fibrillation clinical case |
| topic | cardiotoxicity cardio-oncology atrial fibrillation chemotherapy anthracyclines |
| url | https://www.rpcardio.online/jour/article/view/2592 |
| work_keys_str_mv | AT aaavagimyan relationshipbetweenchemotherapyandatrialfibrillationclinicalcase AT lhmkrtchyan relationshipbetweenchemotherapyandatrialfibrillationclinicalcase AT aagevorkyan relationshipbetweenchemotherapyandatrialfibrillationclinicalcase AT nbkononchuk relationshipbetweenchemotherapyandatrialfibrillationclinicalcase AT lvkakturskiy relationshipbetweenchemotherapyandatrialfibrillationclinicalcase AT ztdjndoyan relationshipbetweenchemotherapyandatrialfibrillationclinicalcase |